Sheela Jitendra Huff

Array ( [id] => 4831195 [patent_doc_number] => 20080127358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Compositions and methods for modulating hedgehog signaling' [patent_app_type] => utility [patent_app_number] => 11/796131 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 138 [patent_figures_cnt] => 138 [patent_no_of_words] => 13567 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11796131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045570 [patent_doc_number] => 20070264243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'REVERSIBLY IMMORTALIZED HEPATOCYTES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/738678 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13288 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264243.pdf [firstpage_image] =>[orig_patent_app_number] => 11738678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5541133 [patent_doc_number] => 20090222938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/296641 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9639 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20090222938.pdf [firstpage_image] =>[orig_patent_app_number] => 12296641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4434439 [patent_doc_number] => 07897833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Animal model for pigment spots' [patent_app_type] => utility [patent_app_number] => 11/785549 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3007 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897833.pdf [firstpage_image] =>[orig_patent_app_number] => 11785549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210463 [patent_doc_number] => 20070249047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Differentiation of Multi-Lineage Progenitor Cells to Respiratory Epithelial Cells' [patent_app_type] => utility [patent_app_number] => 11/736273 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 18905 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249047.pdf [firstpage_image] =>[orig_patent_app_number] => 11736273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178053 [patent_doc_number] => 20070179113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'GM-CSF gene therapy for Crohn\'s disease using an improved regulated expression system' [patent_app_type] => utility [patent_app_number] => 11/730823 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 62511 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179113.pdf [firstpage_image] =>[orig_patent_app_number] => 11730823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939410 [patent_doc_number] => 20080076729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Interferon-beta gene therapy using an improved, regulated expression system' [patent_app_type] => utility [patent_app_number] => 11/730806 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 59034 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11730806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602794 [patent_doc_number] => 20100062978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'METHOD FOR INHIBITING SIGNAL TRANSDUCTION, SIGNAL TRANSDUCTION INHIBITOR TO BE USED THEREIN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/294347 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17127 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062978.pdf [firstpage_image] =>[orig_patent_app_number] => 12294347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669795 [patent_doc_number] => 20080044855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells' [patent_app_type] => utility [patent_app_number] => 11/723610 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5179 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044855.pdf [firstpage_image] =>[orig_patent_app_number] => 11723610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5103029 [patent_doc_number] => 20070186291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Method for generating overexpression of alleles in genes of unknown function' [patent_app_type] => utility [patent_app_number] => 11/726100 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14134 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20070186291.pdf [firstpage_image] =>[orig_patent_app_number] => 11726100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13387 [patent_doc_number] => 07803582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Recombinant vector and use in gene therapy' [patent_app_type] => utility [patent_app_number] => 11/687647 [patent_app_country] => US [patent_app_date] => 2007-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19042 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803582.pdf [firstpage_image] =>[orig_patent_app_number] => 11687647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435619 [patent_doc_number] => 20090170206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHOD FOR HOMOLOGOUS RECOMBINATION IN EUKARYOTIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/296506 [patent_app_country] => US [patent_app_date] => 2007-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10565 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170206.pdf [firstpage_image] =>[orig_patent_app_number] => 12296506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009379 [patent_doc_number] => 08524677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'DNA vaccine as immunoprophylaxis against Kala-azar' [patent_app_type] => utility [patent_app_number] => 11/685413 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8793 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11685413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309712 [patent_doc_number] => 20090016993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'MEDICINAL FORMULATION FOR THE TREATMENT FOR HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 12/279201 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5863 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20090016993.pdf [firstpage_image] =>[orig_patent_app_number] => 12279201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91182 [patent_doc_number] => 07736641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Role for SRY in Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 11/677474 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10177 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/736/07736641.pdf [firstpage_image] =>[orig_patent_app_number] => 11677474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948996 [patent_doc_number] => 20080305122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Ii-Key/antigenic epitope hybrid peptide vaccines' [patent_app_type] => utility [patent_app_number] => 11/708107 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74616 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305122.pdf [firstpage_image] =>[orig_patent_app_number] => 11708107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4689115 [patent_doc_number] => 20080033296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'METHODS FOR DELIVERING MATERIALS INTO BIOLOGICAL SYSTEMS USING SONIC ENERGY' [patent_app_type] => utility [patent_app_number] => 11/675349 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21044 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033296.pdf [firstpage_image] =>[orig_patent_app_number] => 11675349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253338 [patent_doc_number] => 20070134794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells' [patent_app_type] => utility [patent_app_number] => 11/704004 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20717 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134794.pdf [firstpage_image] =>[orig_patent_app_number] => 11704004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258706 [patent_doc_number] => 20070212338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Hybrid cells' [patent_app_type] => utility [patent_app_number] => 11/702661 [patent_app_country] => US [patent_app_date] => 2007-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11331 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212338.pdf [firstpage_image] =>[orig_patent_app_number] => 11702661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198694 [patent_doc_number] => 20070298012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules' [patent_app_type] => utility [patent_app_number] => 11/627743 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 47216 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298012.pdf [firstpage_image] =>[orig_patent_app_number] => 11627743 [rel_patent_id] =>[rel_patent_doc_number] =>)